A similar finding was discovered in China where COVID-19 patients with severe disease activity had a significant reduction of CD4+ and CD8+ cell count (p < 0.05) compared with patients’ with mild-moderate severity (Jiang et al., 2020). The gene discussed is CD8A; the disease is COVID-19.